BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34602004)

  • 1. Fabrication of polymer-based self-assembly nanocarriers loaded with a crizotinib and gemcitabine: potential therapeutics for the treatment of endometrial cancer.
    Yang J; Guo H; Lei J; Zhang S; Zhang S; Bai J; Li S
    J Biomater Sci Polym Ed; 2022 Jan; 33(1):20-34. PubMed ID: 34602004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy.
    Behl A; Sarwalia P; Kumar S; Behera C; Mintoo MJ; Datta TK; Gupta PN; Chhillar AK
    Mol Pharm; 2022 Jul; 19(7):2429-2440. PubMed ID: 35639628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
    Liu D; Zhang W; Liu X; Qiu R
    Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
    Daman Z; Ostad S; Amini M; Gilani K
    Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
    Wang F; Wang Y; Ma Q; Cao Y; Yu B
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of doxorubicin conjugated methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) nanoparticles and study on their
    Shen H; Liu Q; Liu D; Yu S; Wang X; Yang M
    J Biomater Sci Polym Ed; 2021 Sep; 32(13):1703-1717. PubMed ID: 34075850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein delivery nanosystem of six-arm copolymer poly(ε-caprolactone)-poly(ethylene glycol) for long-term sustained release.
    Duan J; Liu C; Liang X; Li X; Chen Y; Chen Z; Wang X; Kong D; Li Y; Yang J
    Int J Nanomedicine; 2018; 13():2743-2754. PubMed ID: 29780245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
    Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
    Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
    Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
    Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
    Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells.
    Hu C; Du W
    Aging (Albany NY); 2020 Nov; 12(24):25767-25777. PubMed ID: 33232271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
    Xiao Y; Gao Y; Li F; Deng Z
    Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells.
    Liu C; Han Q; Liu H; Zhu C; Gui W; Yang X; Li W
    Drug Deliv; 2020 Dec; 27(1):1063-1072. PubMed ID: 32672077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
    Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
    Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.